ArticleScientific reports2025
Development and validation of a model for predicting the risks for delayed onset of lactogenesis stage II for Chinese pregnant women.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Enhancing breastfeeding outcomes in postpartum women with insufficient breast milk supply: protocol for a six-month longitudinal randomized trial of self-administered acupressure.International breastfeeding journal · 2026Article
- Factors influencing delayed lactogenesis II among advanced-age women following cesarean section: a retrospective analysis and predictive model development.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Delayed onset lactogenesis II has adverse effects on breastfeeding and neonatal health. This study aimed to determine the risk factors of DOL II, develop a predictive model for DOL II, and test its validity. This was a retrospective cohort study. A total of 450 pregnant women were involved in this study, including 112 cases with DOL II and 338 cases without DOL II, who were hospitalized between October 2023 and April 2024. Univariate and multivariate logistic regression analyses were conducted to determine the risk factors of DOL II, which were then included in the nomogram. The performance of the nomogram model was evaluated by the area under the receiver operating curve, calibration curve, and Hosmer-Lemeshow test. Decision curve analysis was used to evaluate the clinical efficacy of the nomogram. The results showed that maternal age, pre-pregnancy BMI, gestational age, parity, delivery mode, length of stage II labor, gestational diabetes, EPDS, maternal-infant separation, breastfeeding education during pregnancy, formula use, and onset of breastfeeding within the first hour were independent risk factors. In the derivation cohort, the AUC was 0.786. Youden index was 1.526, with a sensitivity of 0.781 and a specificity of 0.745. In the verification cohort, AUC was 0.748. The nomogram model has good consistency and performance, which can identify women who are at high risk of DOL II.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.